Pursuant to Senate Policy, petitions, opinion polls and unsolicited mass electronic communications cannot be initiated by this office for the 60-day period immediately before the date of a primary or general election. Subscribers currently receiving electronic communications from this office who wish to unsubscribe may do so here.
Capito Statement on Viatris Ceasing Manufacturing Operations in Morgantown
WASHINGTON, D.C. – U.S. Senator Shelley Moore Capito (R-W.Va.) today released the below statement following the announcement that Viatris—a new company created following the November 16 merger between Mylan and Pfizer Inc.’s Upjohn unit—will be ceasing manufacturing operations in Morgantown by July 2021.
“I’m incredibly disappointed to learn that Viatris’ Morgantown plant will be ending its manufacturing operations by July 2021. This is devastating news for the hundreds of hardworking individuals who worked at Mylan that make up the plant’s workforce and the entire community—especially during the holiday season. I will continue to do whatever I can to help the community—whether it’s working with partners at the federal, state, and local levels, to attract new investment to the area or assisting those who have been impacted by the closure.”
# # #